American Telehealth Provider Reviews

Low membership, compounded semaglutide from $99, dietitians included.

Eli Lilly selling Zepbound direct. No membership, published by dose.

Novo Nordisk selling Wegovy direct. Open to government-insured patients.

Real insurance carrier contracts and the widest medication list we found.

In-network video visits, and the only provider publishing its criteria.

Brand-name focus with lab work bundled into the membership.

Board-certified obesity medicine team. Accepts Medicare.

Brand-name only, no compounded options, dedicated insurance team.

Behaviour-change curriculum with a GLP-1 arm attached.

Accepts HSA/FSA cards, but does not publish its membership price.

Both pathways, 24/7 provider access, aggressive pricing claims.

Video visits and clear cancellation terms, but no published price.

FDA-approved only, with every dose tier and expiry date published.

The cheapest compounded tirzepatide we found, on a six-month package.

The most detailed published exclusion list — and a BMI 20 floor.

Established multi-condition telehealth; unclear if the price is all-in.

Menopause-specialised care that also prescribes GLP-1s. HSA/FSA eligible.

No subscription at all, and it publishes what every offer costs after it ends.

No program fee, FDA-approved only, in-person or virtual care.